First Manhattan
ISEE

First Manhattan’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

First Manhattan’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-426,144
Closed -$1.2M – 1539
2017
Q3 		$1.2M Buy
+426,144
New +$1.15M 0.01% 408
2014
Q3 		– Sell
-350
Closed -$14K – 1487
2014
Q2 		$14K Buy
+350
New +$12.8K ﹤0.01% 1149

Other funds holding ISEE

Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Stonepine Capital Management
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
AJO LP
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

First Manhattan's ISEE Position: Q4 2017 in Review

First Manhattan sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2017, closing a stake of 426,144 shares — an estimated $1.2M sold.

First Manhattan first reported a position in ISEE in Q2 2014 and held it in 2 quarters. The position peaked at $1.2M in Q3 2017. 75 funds tracked by Wall St. Rank hold ISEE as of Q4 2017.

  • First Manhattan reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • First Manhattan sold 426,144 IVERIC bio, Inc. Common Stock shares in Q4 2017, an estimated $1.2M.
  • First Manhattan first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 2 quarters.
  • First Manhattan's IVERIC bio, Inc. Common Stock position peaked at $1.2M in Q3 2017.
  • 75 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2017.

Based on First Manhattan's 13F filing for Q4 2017, filed 22 Jan 2018.